申请人:Healy Mark Patrick
公开号:US20110092561A1
公开(公告)日:2011-04-21
A compound of formula (I) or a pharmaceutically acceptable derivative thereof,
wherein, R
1
, R
2
, R
3
, X and Y are as defined in the specification; a process for preparing such compounds; a pharmaceutical composition comprising such compounds; and the use of such compounds in medicine.
一种化合物的分子式为(I),或其药学上可接受的衍生物,其中,R1,R2,R3,X和Y的定义如规范中所述;制备这种化合物的方法;包括这种化合物的药物组合物;以及在医学中使用这种化合物。